A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma. (Q53248440)

12 May 2018

title

A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma. (English)

1 reference

12 May 2018

main subject

phase I clinical trial

0 references

author

Anthony T. Papenfuss

10

1 reference

12 May 2018

Lloyd J. Old

14

object named as

Lloyd J Old

1 reference

12 May 2018

author name string

Junichi Sakamoto

1

1 reference

12 May 2018

Noboru Oriuchi

2

1 reference

12 May 2018

Erito Mochiki

3

1 reference

12 May 2018

Takayuki Asao

4

1 reference

12 May 2018

Andrew M Scott

5

1 reference

12 May 2018

Eric W Hoffman

6

1 reference

12 May 2018

Achim A Jungbluth

7

1 reference

12 May 2018

Takanori Matsui

8

1 reference

12 May 2018

F T Lee

9

1 reference

12 May 2018

Hiroyuki Kuwano

11

1 reference

12 May 2018

Toshitada Takahashi

12

1 reference

12 May 2018

Keigo Endo

13

1 reference

12 May 2018

publication date

1 November 2006

1 reference

12 May 2018

published in

Cancer Science

1 reference

12 May 2018

volume

97

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

1248-1254

1 reference

12 May 2018

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Helicobacter pylori and gastric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Treatment of localized gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Cetuximab in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

The epidemiology of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00324.X

10.1111/J.1349-7006.2006.00324.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

release_57dwhncwqfbhhlbdre53eq4yni

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/57dwhncwqfbhhlbdre53eq4yni

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

12 May 2018